CAS 1191996-10-7

Formule : C22H27ClN4O5

InChI : InChI=1S/C22H27ClN4O5/c1-14(2)9-18(22(31)24-20-7-8-26(25-20)11-15(29)13-28)27-12-16(10-21(27)30)32-19-6-4-3-5-17(19)23/h3-8,10,14-15,18,28-29H,9,11-13H2,1-2H3,(H,24,25,31)/t15-,18-/m0/s1

Code InChI : HMUMWSORCUWQJO-YJBOKZPZSA-N

SMILES : CC(C)C[C@@H](C(=O)NC1=NN(C=C1)C[C@@H](CO)O)N2CC(=CC2=O)OC3=CC=CC=C3Cl

(2S)-2-[3-(2-Chlorophenoxy)-5-oxo-2H-pyrrol-1-yl]-N-[1-[(2S)-2,3-dihydroxypropyl]pyrazol-3-yl]-4-methylpentanamide

CAS : 1191996-10-7

(2S)-2-[3-(2-Chlorophenoxy)-5-oxo-2H-pyrrol-1-yl]-N-[1-[(2S)-2,3-dihydroxypropyl]pyrazol-3-yl]-4-methylpentanamide is a drug that belongs to the class of drugs called dipeptidyl peptidase IV (DPPIV) inhibitors. It has been shown to reduce postprandial blood glucose levels in humans. This compound binds to glucokinase and inhibits the enzyme's activity, leading to decreased glucose production by the liver cells. The pharmacokinetic properties of this drug have not been fully investigated, but it is known that it is metabolized in the liver. In addition, this drug has not been studied for safety in patients with impaired hepatic function.

Formule : C₂₂H₂₇ClN₄O₅

Degré de pureté : Min. 95%

Masse moléculaire : 462.9 g/mol

Ref: 3D-RXB99610

Sinogliatin

CAS : 1191996-10-7

Sinogliatin, a glucokinase activator, is used potentially for the treatment of type 2 diabetes.

Formule : C₂₂H₂₇ClN₄O₅

Couleur et forme : Solid

Masse moléculaire : 462.93

Ref: TM-T28781

(S)-2-(4-(2-Chlorophenoxy)-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)-N-(1-((S)-2,3-dihydroxypropyl)-1H-pyrazol-3-yl)-4-methylpentanamide

CAS : 1191996-10-7

Formule : C₂₂H₂₇ClN₄O₅

Masse moléculaire : 462.9266

Ref: IN-DA000IBL